From: Investigating the relationship between BMI across adulthood and late life brain pathologies
Relative change in WMHV (95% CI) | β-amyloid adjusted OR (95% CI) | WBV β coefficient (95% CI) | Mean HV β coefficient (95% CI) | |
---|---|---|---|---|
Model 2(c) | Model 2(c) | Model 2(c) | Model 2(c) | |
36–43 years WMHV: Model 2: n = 390 Amyloid: Model 2: n = 391 WBV/HV: Model 2: n = 382 | 0.98 (0.89, 1.09) | 0.95 (0.72, 1.26) | 1.4 (− 3.2, 5.9) | 0.006 (− 0.023, 0.035) |
43–53 years WMHV: Model 2: n = 391 Amyloid: Model 2: n = 391 WBV/HV: Model 2: n = 383 | 0.96 (0.86, 1.08) | 0.89 (0.67, 1.17) | −1.4 (− 6.0, 3.3) | − 0.013 (− 0.042, 0.017) |
53–60/64 years WMHV: Model 2: n = 394 Amyloid: Model 2: n = 395 WBV/HV: Model 2: n = 386 | 1.01 (0.90, 1.13) | 0.84 (0.63, 1.10) | − 1.7 (− 6.3, 2.9) | 0.007 (− 0.022, 0.036) |
60/64–69 years WMHV: Model 2: n = 395 Amyloid: Model 2: n = 396 WBV/HV: Model 2: n = 387 | 1.00 (0.89, 1.12) | 0.95 (0.73, 1.25) | − 6.0 (− 10.5, − 1.5) | − 0.013 (− 0.042, 0.016) |